Cita APA (7a ed.)

A, L., JJ, J., ER, A., RB, N., R, G., MD, P., & EJ, M. (2014). Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer. Dove Medical Press.

Cita Chicago Style (17a ed.)

A, Lucero-Acuña, Jeffery JJ, Abril ER, Nagle RB, Guzman R, Pagel MD, y Meuillet EJ. Nanoparticle Delivery of an AKT/PDK1 Inhibitor Improves the Therapeutic Effect in Pancreatic Cancer. Dove Medical Press, 2014.

Cita MLA (8a ed.)

A, Lucero-Acuña, et al. Nanoparticle Delivery of an AKT/PDK1 Inhibitor Improves the Therapeutic Effect in Pancreatic Cancer. Dove Medical Press, 2014.